Фβͼ

Physician Patient
Alan Nyitray, PhD

Alan G. Nyitray, PhD

Associate Professor

Locations

  • Department of Psychiatry and Behavioral Medicine
    Center for AIDS Intervention Research (CAIR)
    ФβͼCancer Center

Contact Information

Education

PhD, Epidemiology, Mel and Enid Zuckerman College of Public Health, University of Arizona
MS, Mass Communications, Oklahoma State University
BS, Radio, Television, and Film, Oklahoma State University

Biography

Dr. Nyitray's primary research interest is in screening interventions for human papillomavirus (HPV)-associated disease with a focus on anal cancer. This research covers anal cancer and precancer screening interventions that seek to help gay, bisexual, and other men who have sex with men detect precancers or early invasive cancer when the cancer is much more treatable. His research initially focused on the epidemiology and natural history of HPV infection and HPV antibodies, estimating the prevalence, incidence, persistence, duration of infection, clearance, and the transmission potential of HPV among heterosexual men, gay and bisexual men, and heterosexual couples. Dr. Nyitray is also interested in creating HPV vaccine interventions to increase uptake of vaccination in adults.

Research Areas of Interest

  • Anus Neoplasms
  • Early Detection of Cancer
  • Epidemiology
  • HIV
  • Mass Screening
  • Molecular Epidemiology
  • Papillomavirus Infections
  • Sexual and Gender Minorities
  • Sexual Behavior
  • Sexual Health

Research Interests

Human papillomavirus

Anal cancer

Publications

  • (Garg A, Damgacioglu H, Sigel K, Nyitray AG, Clifford GM, Curran T, Lazenby G, Meissner EG, Sterba K, Sonawane K, Deshmukh AA.) J Natl Cancer Inst. 2024 Sep 01;116(9):1508-1512 PMID: 38837335 PMCID: PMC11378306 06/05/2024

  • (Deshmukh AA, Lin YY, Damgacioglu H, Shiels M, Coburn SB, Lang R, Althoff KN, Moore R, Silverberg MJ, Nyitray AG, Chhatwal J, Sonawane K, Sigel K.) J Natl Cancer Inst. 2024 Sep 01;116(9):1450-1458 PMID: 38713084 PMCID: PMC11378305 05/07/2024

  • (Amboree TL, Kuo J, Sirak BA, Schneider JA, Nyitray AG, Hwang LY, Chiao EY, Giuliano AR, Fujimoto K.) Heliyon. 2024 Jun 15;10(11):e32336 PMID: 38933939 PMCID: PMC11200335 06/27/2024

  • (Nitkowski J, Ridolfi TJ, Lundeen SJ, Giuliano AR, Chiao E, Fernandez ME, Schick V, Smith JS, Bruggink P, Brzezinski B, Nyitray AG.) medRxiv. 2024 Apr 22 PMID: 38712301 PMCID: PMC11071571 05/07/2024

  • (Nitkowski J, Ridolfi TJ, Lundeen SJ, Giuliano AR, Chiao EY, Fernandez ME, Schick V, Smith JS, Brzezinski B, Nyitray AG.) Sex Health. 2024 Apr;21 PMID: 38683939 SCOPUS ID: 2-s2.0-85191911442 04/29/2024

  • (Bennis SL, Rohloff CT, Zhang Z, Kohli N, Zoschke IN, Rosser BRS, Nyitray AG, Wilkerson JM, Stull CL, Khariwala SS, Ross MW.) Sex Transm Dis. 2024 Apr 01;51(4):289-294 PMID: 38430512 PMCID: PMC10978235 SCOPUS ID: 2-s2.0-85189192434 03/03/2024

  • (Nyitray AG, McAuliffe TL, Liebert C, Swartz MD, Deshmukh AA, Chiao EY, Weaver L, Almirol E, Kerman J, Schneider JA, Wilkerson JM, Hwang LY, Smith D, Hazra A, Prevent Anal Cancer Palpation Study Team.) Lancet Reg Health Am. 2024 Mar;31:100704 PMID: 38440068 PMCID: PMC10910307 SCOPUS ID: 2-s2.0-85186586541 03/05/2024

  • (Sonawane K, Garg A, Meissner EG, Damgacioglu H, Hill E, Nyitray AG, Deshmukh AA.) JAMA Netw Open. 2024 Feb 05;7(2):e2356875 PMID: 38376844 PMCID: PMC10879942 SCOPUS ID: 2-s2.0-85185317157 02/20/2024

  • (Nyitray AG, Rosser BRS, Hazra A, Nitkowski J, Smith D, Brzezinski B, Ridolfi TJ, Schneider JA, Chiao EY, Sanos S, Mkonyi E, Mgopa LR, Ross MW.) medRxiv. 2024 Feb 01 PMID: 38352524 PMCID: PMC10862988 02/14/2024

  • (Amboree TL, Kuo J, Sirak BA, Schneider JA, Nyitray AG, Hwang LY, Chiao EY, Giuliano AR, Fujimoto K.) Heliyon. 15 June 2024;10(11) SCOPUS ID: 2-s2.0-85195171082 06/15/2024

  • (Ross MW, Bennis SL, Zoschke N, Simon Rosser BR, Stull CL, Nyitray AG, Khariwala SS, Nichols M, Flash C, Wilkerson M.) Venereology (Basel). 2023 Dec;2(4):180-193 PMID: 38515606 PMCID: PMC10956645 03/22/2024